Mobile Drug Testing Services for Transportation Companies

DOT drug testing follows specific federal guidelines that differ from standard workplace drug testing in several important ways:

• Tests must be conducted using DOT-specific forms and procedures
• Specimens must be analyzed at SAMHSA-certified laboratories
• Results must be reviewed by a qualified Medical Review Officer (MRO)
• Specific testing panels are mandated (5-panel drug test for marijuana, cocaine, amphetamines, opiates, and PCP)
• Split-specimen collection is required, allowing for independent testing of positive results
• Strict chain of custody procedures must be followed
• Record retention requirements are more extensive than non-DOT testing

QuickCare's DOT drug testing service ensures compliance with all these specific requirements while providing the convenience of mobile, on-site testing.

DOT regulations require that a minimum percentage of safety-sensitive employees be randomly tested each year. The exact percentages can change annually but currently stand at:

• 50% annual random drug testing rate (meaning that if you have 100 safety-sensitive employees, you must conduct at least 50 random drug tests throughout the year)
• 10% annual random alcohol testing rate

These tests must be spread reasonably throughout the year in a truly random pattern. Each employee in the random testing pool must have an equal chance of being selected each time a random draw occurs, regardless of whether they've been previously tested.

QuickCare's random testing program ensures you meet these requirements through scientifically valid random selection methods and helps schedule testing to minimize operational disruption while maintaining the element of surprise required by DOT regulations.

When an employee tests positive on a DOT drug test, a specific process must be followed:

1. Medical Review: The Medical Review Officer (MRO) will contact the employee to discuss any legitimate medical explanations for the positive result.
2. Result Confirmation: If no legitimate medical explanation exists, the MRO will verify the result as positive and notify the employer.
3. Immediate Removal: The employee must be immediately removed from safety-sensitive functions.
4. Referral to SAP: The employer must provide the employee with information about contacting a Substance Abuse Professional (SAP).
5. Evaluation and Treatment: The employee must be evaluated by the SAP and complete any recommended treatment program.
6. Return-to-Duty Process: Before returning to safety-sensitive duties, the employee must:
   • Receive a follow-up evaluation from the SAP
   • Pass a return-to-duty drug test
   • Be subject to follow-up testing (minimum of 6 tests in the first 12 months, can continue for up to 5 years)

QuickCare provides guidance on handling positive results and can coordinate return-to-duty and follow-up testing as part of our comprehensive DOT compliance services.

Yes, QuickCare offers 24/7 emergency response testing for post-accident situations. We understand that accidents don't just happen during business hours, and DOT regulations require post-accident testing to be conducted as soon as possible (within 8 hours for alcohol and 32 hours for drugs).

Our emergency response team can be dispatched to accident scenes, hospitals, or company facilities at any time of day or night to ensure timely collection and preservation of specimens. This service is available throughout our service area.

To arrange emergency post-accident testing, clients can call our dedicated 24-hour emergency response line. We recommend programming this number into your safety protocols and emergency contact lists.

Yes, QuickCare offers complete DOT random testing consortium management services. Our Consortium/Third-Party Administrator (C/TPA) services are particularly valuable for smaller transportation companies that may find it challenging to maintain their own random testing programs.

Our consortium management services include:

• Maintenance of your random testing pool
• Scientifically valid random selections
• Scheduling and coordination of random testing
• Documentation of selection process
• Statistical reports and annual summaries
• Regulatory compliance monitoring
• Record retention in accordance with DOT requirements

By joining our consortium, you can ensure your company meets DOT's random testing requirements while benefiting from the convenience and cost-effectiveness of a shared random testing pool.

Maintaining a secure chain of custody is critical for DOT drug testing validity. QuickCare implements rigorous procedures to ensure specimen integrity from collection through laboratory analysis:

1. Certified Collectors: All specimens are collected by DOT-certified collectors trained in proper collection and documentation procedures.
2. DOT Forms: We use official DOT chain of custody forms with unique specimen ID numbers.
3. Sealed Specimens: Specimens are sealed with tamper-evident tape in the donor's presence.
4. Direct Observation: Collectors maintain visual control of specimens until properly sealed and documented.
5. Secure Transport: Sealed specimens are transported in locked containers with temperature monitoring when necessary.
6. Documentation Trail: Every transfer of the specimen is documented on the chain of custody form.
7. Laboratory Verification: Upon arrival at the laboratory, specimen seals are verified as intact before testing begins.

Our chain of custody procedures meet or exceed all DOT requirements, ensuring the legal defensibility of test results even when specimens are collected at mobile locations.